DermSpectra™ Awarded Grant by Walter Reed National Military Medical Center to Expand Services for Full-Body Skin Imaging
Posted on December 9, 2016 by DermSpectra™
(TUSCON, AZ) – DermSpectra™ Automated Total Body Digital Skin Imaging System (DermSpectra) is pleased to announce that they are the recipient of a grant for an AMEDD Advanced Medical Technology Initiative (AAMTI) through Walter Reed National Military Medical Center (WRNMMC). This grant provides WRNMMC the opportunity to evaluate a full body skin-screening platform, in a clinical setting, that provides standardized high-resolution imaging across all patients over time. Initially, full-body skin images collected will be interpreted by dermatologists at WRNMMC under a patient care protocol as part of its teledermatology and skin cancer evaluation training for the dermatology residency-training program.
A revolutionary new technology for military medicine, DermSpectra offers advanced total body imaging to track and monitor critical skin changes (skin cancers, eczema, moles, psoriasis, and rashes) over time. DermSpectra fills a critical gap in military medicine, enabling minimally trained individuals to acquire digital skin images that can help physicians identify, monitor, and diagnosis skin abnormalities. Through increased opportunities for early and preventive treatment, DermSpectra’s patented process gives personnel access to consistent skin monitoring before, during and after deployment and tours.
Allowing for more thorough skin screenings that can easily be uploaded to electronic medical records, DermSpectra’s advanced medical technology is revolutionizing military healthcare. In addition to standardized skin imaging, other benefits include monitoring of skin changes due to exposure to environments. Furthermore, DermSpectra can assist in Military Entrance Processing Stations (MEPS), pre- and post-deployment screenings, retirement screenings, and in the evaluation of patients in remote locations.
The WRNMMC grant includes funding for a clinical study that will evaluate the application and benefits of consistent total body imaging in military medical applications. The clinical trial will also test the practicality and effectiveness of total body imaging as a way to analyze and develop treatment plans for skin cancers and other integumentary diseases among active military personnel.
“The opportunity to partner and conduct IRB clinical studies with the US Army will allow us to demonstrate the precision of the DermSpectra Automated Total Body Digital Skin Imaging System,” states Karleen Seybold, Founder and Chief Executive Officer of DermSpectra. “We believe that every person should have a digital skin image of their body in their medical record.”
DermSpectra Automated Total Body Digital Skin Imaging System provides university medical centers, cancer centers, and dermatologists an automated solution that can visually detect, track, and monitor vital skin irregularities, like moles, psoriasis, eczema, and lesions. DermSpectra’s advanced medical technology changes the way physicians visually capture and compare skin changes by providing objective, ultra-high resolution images to aid in early detection of skin cancers. For more information, call 1-800-610-2079.